Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1096
https://www.valueinhealthjournal.com/article/S1098-3015(16)32462-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1027
First Page :
A535
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32462-7&doi=10.1016/j.jval.2016.09.1096